END-STAGE KIDNEY DISEASE
Clinical trials for END-STAGE KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for END-STAGE KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Nighttime dialysis matches daytime in cleaning blood, study finds
Disease control CompletedThis study compared two types of peritoneal dialysis for people with end-stage kidney disease: one done manually during the day (CAPD) and one done automatically at night (APD). 137 non-diabetic adults participated, each trying both methods for 12 weeks. The goal was to see if ni…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: NA • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New implant could make dialysis easier for kidney patients
Disease control CompletedThis study tested a special collagen implant that slowly releases a drug called sirolimus. It was placed around a new blood vessel connection (fistula) during surgery in 136 people aged 65+ with kidney failure on dialysis. The goal was to see if the implant helps the fistula matu…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:05 UTC
-
New implant could keep dialysis lifelines open longer
Disease control CompletedThis study tested a special collagen implant that slowly releases sirolimus around a new dialysis fistula (a surgically created blood vessel connection). The goal was to see if it helps the fistula become usable for dialysis sooner and stay open longer. The trial involved 269 adu…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE3 • Sponsor: Vascular Therapies, Inc. • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC
-
Kidney drug study halted early, but safety data collected
Knowledge-focused CompletedThis early-stage study tested a single dose of an experimental drug called MK-2060 in 14 people with advanced chronic kidney disease. The main goal was to check for side effects, especially bleeding, and to measure how the drug moves through the body. Only the first part of the s…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated May 01, 2026 15:59 UTC
-
Kidney drug study: how bodies process AZD4144
Knowledge-focused CompletedThis study tested a single dose of the drug AZD4144 in 41 adults to see how their bodies processed it. Participants included people with severe kidney disease, those with end-stage kidney disease, and healthy volunteers. The goal was to understand the drug's safety and how it beh…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Kidney disease drug study: how does MK-5684 behave?
Knowledge-focused CompletedThis study looked at how the drug MK-5684 is processed in men with severe kidney failure or end-stage kidney disease compared to healthy men. Twenty-four men took a single dose, and researchers measured drug levels in the blood over time. The goal was to understand how kidney pro…
Matched conditions: END-STAGE KIDNEY DISEASE
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:52 UTC